Publications by authors named "K Jarman"
Background: People who smoke cigars often have misperceptions about the associated risks, contributing to rises in smoking rates. This study investigates the perceived warning effectiveness (PWE) of health warning labels (HWLs) on cigar packages. We tested the impact of warning type and warning size in the HWLs on PWE and other health outcomes.
View Article and Find Full Text PDFBackground: Communication campaigns for health warning labels (HWLs) are an evidence-based strategy to reduce tobacco use. No research has examined campaign messages to support graphic HWLs for little cigars and cigarillos (LCCs).
Methods: We developed four message types for graphic LCC HWLs: (1) Explanatory (2) Testimonial (3) Inquisitive and (4) Recommendation, depicting colon, lung, and esophageal cancer.
Objective: Little evidence exists on which cigar warning statement attributes may impact cigar warning effectiveness; research is needed to identify the most effective cigar warning topics and text. This study was designed to inform the development of improved cigar warnings.
Design: We conducted a choice-based conjoint experiment.
To characterize regulatory practices related to nonmedical cannabis warning labels in states across the United States that have legalized retail nonmedical cannabis. In March 2024, we conducted a content analysis of regulations for nonmedical cannabis warning labels required on product packages in 20 states where, as of March 2024, adults could legally purchase nonmedical cannabis in retail environments. For each state, we examined requirements related to warning label content and characteristics.
View Article and Find Full Text PDFArticle Synopsis
- Drug resistance is making existing antimalarials ineffective, highlighting the urgent need for new treatments.
- Researchers identified a promising new chemotype, cyclopropyl carboxamide, through screening a library of compounds, leading to the development of a strong candidate, WJM280, which is effective against malaria without harming human cells.
- Further studies revealed that resistant parasites have mutations in the cytochrome b gene, confirming it as the drug target, but improving the compound's stability and effectiveness in mouse models still needs to be addressed.